IP Library › Granted Patent US 8,388,962
Granted Patent B2
US 8,388,962 · App. 11/883,725 · Granted Mar 5, 2013

Molecules and methods of using same for treating MCP-1/CCR2 associated diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,388,962
App. No.
11/883,725
Granted
Mar 5, 2013
Kind
B2
Abstract

Molecules and compositions including same for the isolation of MCP-1 and treatment of CCR2/MCP-1 associated diseases.

Claims (4)

1. A molecule comprising the amino acid sequence as set forth in SEQ ID NO: 14 or 15.

2. The molecule of claim 1 , attached to a non-proteinaceous moiety.

3. The molecule of claim 2 , wherein said non-proteinaceous moiety is selected from the group consisting of polyethylene glycol (PEG), Polyvinyl pyrrolidone (PVP), poly(styrene comaleic anhydride) (SMA), and divinyl ether and maleic anhydride copolymer (DIVEMA).

4. A pharmaceutical composition comprising the molecule of claim 1 and a pharmaceutically acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2018
From: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
To: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
Reel/Frame 046493/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2007
From: KARIN, NATHAN; WILDBAUM, GIZI; ZOHAR, YANIV; IZHAK, LIAT; WEINBERG, URI
To: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
Reel/Frame 019800/0946 →